All articles

Novo Nordisk drugs for the treatment of diabetes in adults - Tresiba® (insulin degludec) and Ryzodeg® (insulin degludec/insulin aspart), has been granted European Commission’s approval across all EU member states....
Read more

The European Medicines Agency (EMA) supported their previous opinion to suspend Tredaptive, Pelzont and Trevaclyn from the market (editor note: Pelzont is the brand name of Tredaptive in Italy and Trevaclyn in Italy and Portugal). Those nicotinic acid/laropirant based drugs were used for treatment of...
Read more

In July 2011 Synthos, a Polish chemical company, one of the biggest manufacturers of rubber in Europe, and Global Bioenergies, a French company developing the sustainable way of olefins production, signed an agreement. Encouraged by the success of bio-sourced isobutene, Synthos entered a strategic pa...
Read more

There is a great chance that Europe, after decades of impasse, will have a new unified patent law. Competitiveness Council and MEPs (Member of the European Parliament) finally reached a settlement and adopted the draft law, which will significantly reduce costs of new patents implementation. Nowadays...
Read more

Penta Investments, the Central European investment group, has signed an agreement to sell 100% stake in Alpha medical a.s. and Alpha medical Polska Sp. z o.o. to Mid Europa Partners. The transaction includes the whole Alpha Medical group and its assets in the Czech Republic, Slovakia and Poland. Alph...
Read more

Mabion SA – polish biotech company – submitted to the Serbian Ministry of Health all the scientific and legal documentation required to register the clinical trials of MabionCD20 – a drug that is to be used in blood cancer and rheumatoid arthritis treatment. Serbia is the second of all 8 selected Eur...
Read more

To celebrate 60 years since the pivotal moment in history when DNA was discovered as a three-dimensional double-helix structure- EuropaBio announces the launch of ‘European Biotech Week’. It will take place across Europe every year during the first week of October and will encourage all European citi...
Read more

The CONTIPRO company was created in 1990 by Vladimír Velebnýand Petr Pinkas. Its name is a composite of “connective tissue products”, which are widely used in the pharmaceutical and cosmetic industries. The companyhas been involved in R&D and biotechnological production of active ingredients for the ...
Read more

Wellington Partners - a Venture Capital firm that invests in promising life sciences start-up companies throughout Europe managed to gather 70 million € from leading international investors. The target group for the new fund includes companies that operate in innovative medical device sector, diagnos...
Read more

In an exciting twist, two companies have been announced as winners of EuropaBio’s Most Innovative Biotech SME Award 2012. Commission Vice President Tajani who presented the award, during the event hosted by Dr. Kay Swinburne MEP at the European Parliament on 19th September, named both Austrian healt...
Read more

Actavis has introduced a drug containing atorvastatin in 8 european markets where patent protection of Lipitor® /Zarator® from Pfizer has just expired. Lipitor®`s generic equivalent produced by Actavis will be from now available in Germany, Denmark, UK, France, Netherlands, France and Italy....
Read more

EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today by the Innovative Medicines Initiative (IMI) public-private partnership, a €223,7 million programme to tackle antimicrobial resistance and to speed up the development of new antibiotics....
Read more